Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis

NCT04530318 is registered in ClinicalTrials.gov with Judit Pich as lead sponsor.

NCT NCT04530318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04530318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis
Lead sponsor
Judit Pich
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 27, 2020
Completion date
March 15, 2026
Enrollment
45 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis